Insulin-like and non-insulin-like selenium actions in 3T3-L1 Adipocytes

被引:15
作者
Heart, E [1 ]
Sung, CK [1 ]
机构
[1] Univ So Calif, Dept Physiol & Biophys, Keck Sch Med, Los Angeles, CA 90089 USA
关键词
selenium; insulin signaling; phosphatidylinositol-3-kinase; glucose transport; antilipolysis;
D O I
10.1002/jcb.10395
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In insulin-sensitive 3T3-L1 adipocytes, selenium stimulates glucose transport and antilipolysis and these actions of selenium, like insulin actions, are sensitive to wortmanin, an inhibitor of phosphatidylinositol-3-kinase (PI3K). Selenium stimulates PI3K activity that is sustained up to 24 h. Selenium after 5-10 min increases tyrosine phosphorylation of selective cellular proteins, but after 24 h overall tyrosine phosphorylation is increased. Tyrosine phosphorylation of insulin receptor substrate 1 is detected when enriched by immunoprecipitation with anti-PI3K antibody. Selenium, however, does not stimulate insulin receptor tyrosine kinase activity. Selenium also increases phosphorylation of other insulin signaling proteins, including Akt and extracellular signal regulated kinases. Selenium-stimulated glucose transport is accompanied by increases in glucose transporter-1 content in the plasma membrane. These data are consistent with similar selenium action in glucose transport in 3T3-L1 fibroblasts expressing mainly GLUT1. In chronic insulin-induced insulin resistant cells, selenium unlike insulin fully stimulates glucose transport. In summary, selenium stimulates glucose transport and antilipolysis in a PI3K-dependent manner, but independent of insulin receptor activation. Selenium exerts both insulin-like and non-insulin-like actions in cells.
引用
收藏
页码:719 / 731
页数:13
相关论文
共 37 条
[1]   PHOSPHATIDYLINOSITOL 3'-KINASE IS ACTIVATED BY ASSOCIATION WITH IRS-1 DURING INSULIN STIMULATION [J].
BACKER, JM ;
MYERS, MG ;
SHOELSON, SE ;
CHIN, DJ ;
SUN, XJ ;
MIRALPEIX, M ;
HU, P ;
MARGOLIS, B ;
SKOLNIK, EY ;
SCHLESSINGER, J ;
WHITE, MF .
EMBO JOURNAL, 1992, 11 (09) :3469-3479
[2]   Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats [J].
Battell, ML ;
Delgatty, HLM ;
McNeill, JH .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 179 (1-2) :27-34
[3]   Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats [J].
Becker, DJ ;
Reul, B ;
Ozcelikay, AT ;
Buchet, JP ;
Henquin, JC ;
Brichard, SM .
DIABETOLOGIA, 1996, 39 (01) :3-11
[4]   Insulin-like effects of vanadate and selenate on the expression of glucose-6-phosphate dehydrogenase and fatty acid synthase in diabetic rats [J].
Berg, EA ;
Wu, JY ;
Campbell, L ;
Kagey, M ;
Stapleton, SR .
BIOCHIMIE, 1995, 77 (12) :919-924
[5]   PROTEIN-KINASE-B (C-AKT) IN PHOSPHATIDYLINOSITOL-3-OH INASE SIGNAL-TRANSDUCTION [J].
BURGERING, BMT ;
COFFER, PJ .
NATURE, 1995, 376 (6541) :599-602
[6]   PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION IS REQUIRED FOR INSULIN STIMULATION OF PP70 S6 KINASE, DNA-SYNTHESIS, AND GLUCOSE-TRANSPORTER TRANSLOCATION [J].
CHEATHAM, B ;
VLAHOS, CJ ;
CHEATHAM, L ;
WANG, L ;
BLENIS, J ;
KAHN, CR .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (07) :4902-4911
[7]  
CLARK L, 1996, JAMA-J AM MED ASSOC, V277, P1520
[8]   Comparison of the signaling abilities of the cytoplasmic domains of the insulin receptor and the insulin receptor-related receptor in 3T3-L1 adipocytes [J].
Dandekar, AA ;
Wallach, BJ ;
Barthel, A ;
Roth, RA .
ENDOCRINOLOGY, 1998, 139 (08) :3578-3584
[9]  
DIDICHENKO S, 1996, CURR BIOL, V10, P1271
[10]  
EZAKI O, 1990, J BIOL CHEM, V265, P1124